T. Rowe Price Associates
STIM icon

T. Rowe Price Associates’s Neuronetics STIM Stock Holding History

T. Rowe Price Associates’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Sell
24,246
-12,615
-34% -$18.4K ﹤0.01% 3210
2026
Q1 		$54K Hold
36,861
– – ﹤0.01% 3069
2025
Q4 		$51K Hold
36,861
– – ﹤0.01% 3030
2025
Q3 		$101K Hold
36,861
– – ﹤0.01% 2926
2025
Q2 		$129K Buy
36,861
+17,761
+93% +$70.1K ﹤0.01% 2841
2025
Q1 		$71K Hold
19,100
– – ﹤0.01% 2883
2024
Q4 		$31K Hold
19,100
– – ﹤0.01% 2976
2024
Q3 		$15K Hold
19,100
– – ﹤0.01% 2996
2024
Q2 		$35K Hold
19,100
– – ﹤0.01% 2889
2024
Q1 		$91K Hold
19,100
– – ﹤0.01% 2799
2023
Q4 		$56K Hold
19,100
– – ﹤0.01% 2794
2023
Q3 		$26K Hold
19,100
– – ﹤0.01% 2840
2023
Q2 		$42K Hold
19,100
– – ﹤0.01% 2821
2023
Q1 		$56K Hold
19,100
– – ﹤0.01% 2779
2022
Q4 		$131K Hold
19,100
– – ﹤0.01% 2656
2022
Q3 		$61K Buy
19,100
+7,600
+66% +$27.6K ﹤0.01% 2806
2022
Q2 		$37K Sell
11,500
-2,313
-17% -$6.71K ﹤0.01% 2894
2022
Q1 		$42K Buy
+13,813
New +$46.7K ﹤0.01% 2935
2021
Q4 		– Sell
-18,913
Closed -$124K – 3038
2021
Q3 		$124K Buy
18,913
+6,200
+49% +$59.5K ﹤0.01% 2806
2021
Q2 		$204K Buy
12,713
+1,913
+18% +$26.4K ﹤0.01% 2726
2021
Q1 		$134K Buy
+10,800
New +$166K ﹤0.01% 2758
2018
Q4 		– Sell
-231,386
Closed -$7.42M – 2592
2018
Q3 		$7.42M Sell
231,386
-45,514
-16% -$1.38M ﹤0.01% 1416
2018
Q2 		$7.37M Buy
+276,900
New +$7.53M ﹤0.01% 1397

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates's STIM Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Neuronetics (STIM) stake by 34% in Q2 2026, selling an estimated $18.4K and leaving 24,246 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #3210.

T. Rowe Price Associates first reported a position in STIM in Q2 2018 and has held it in 23 quarters since. The position peaked at $7.42M in Q3 2018. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • T. Rowe Price Associates held 24,246 shares of Neuronetics worth $32K as of Q2 2026.
  • T. Rowe Price Associates sold 12,615 Neuronetics shares in Q2 2026, an estimated $18.4K.
  • Neuronetics made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3210 holding.
  • T. Rowe Price Associates first reported a position in Neuronetics in Q2 2018 and has held it in 23 quarters since.
  • T. Rowe Price Associates's Neuronetics position peaked at $7.42M in Q3 2018.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.